Skip to main content

Division of Pulmonary & Critical Care Medicine

pulmonary_hero_1920x500

The Division of Pulmonary and Critical Care Medicine comprises of 37 full-time faculty members who have an extensive range of clinical and research interests. This allows us to offer ample opportunities for one-on-one faculty-fellow mentorship while also delivering breadth and depth of expertise. Our aim is to provide exceptional care to our patients as well as outstanding clinical and research training to our fellows. 

Our division treats patients with a range of pulmonary and respiratory ailments, including obstructive airway diseases such as asthma and COPD, restrictive lung diseases such as idiopathic pulmonary fibrosis and occupationally acquired lung disease, sleep-related breathing disorders such as obstructive sleep apnea, and acute lung injury in the critical care setting. Our interventional colleagues work closely with Oncology to diagnose and treat lung cancer patients. The Transplant Pulmonary group evaluates patients who are being considered for lung transplant and cares for post-operative transplant patients.

UVA Pulmonary & Critical Care Fellowship Program

The Pulmonary and Critical Care Fellowship at UVA is a three-year program that provides a strong background in clinical pulmonary medicine and the management of critically ill patients. At least 12 months of research experience is provided in the clinical research track. A second 18-month research experience is offered for fellows interested in the academic research track. Research may be in either clinical or basic science.

Fellowship Application

Sleep Medicine Fellowship

We are an ACGME-accredited clinical Sleep Medicine Fellowship program that spans 12 months. The overarching goal of the UVA Sleep Medicine Fellowship is to provide a supportive learning environment for our fellows to become comprehensive experts in sleep medicine. Upon completing the fellowship program, our fellows will be board-eligible in Sleep Medicine.

Learn More
  • The flu situation in the United States right now is, in a word, bad. Infections have skyrocketed in recent weeks, filling hospitals nearly to capacity; viral levels are “high” or “very high” in most of the country. What the U.S. is experiencing right now “fits within the general spectrum of what we would expect,” Taison Bell, an infectious-disease and critical-care physician at the University of Virginia Health System.
    Dr. Taison Bell talks with The Atlantic about how flu season is impacting hospitals. “The Flu Really Is That Bad.”

    The flu situation in the United States right now is, in a word, bad. Infections have skyrocketed in recent weeks, filling hospitals nearly to capacity; viral levels are “high” or “very high” in most of the country. What the U.S. is experiencing right now “fits within the general spectrum of what we would expect,” Taison Bell, an infectious-disease and critical-care physician at the University of Virginia Health System.

    Read More
  • Cold weather can be particularly challenging for people with asthma and other breathing problems. When temperatures drop, the body has to work overtime just to warm the air people breathe. Doctor Kyle Enfield, said sudden temperature changes are one reason emergency room visits tend to rise this time of year.
    UVA Health’s Dr. Kyle Enfield explains how cold weather can worsen asthma and other respiratory conditions.

    Cold weather can be particularly challenging for people with asthma and other breathing problems. When temperatures drop, the body has to work overtime just to warm the air people breathe. Doctor Kyle Enfield, said sudden temperature changes are one reason emergency room visits tend to rise this time of year.

    Watch Video
  • Imre Noth, MD, Professor in the Department of Medicine, investigates interstitial lung diseases using translational biology and clinical trials to develop and monitor new treatments. "I work in a rare and uncommon set of diseases called interstitial lung diseases. These can be deadly with a high mortality, and I’ve had the benefit of living through two approved therapies, with more coming, from an era that had none." —Imre Noth, MD, Professor of the Department of Medicine, Chief of the Division of Pulmonary and Critical Care Medicine
    Imre Noth, MD, Research In Motion

    Imre Noth, MD, Professor in the Department of Medicine, investigates interstitial lung diseases using translational biology and clinical trials to develop and monitor new treatments. "I work in a rare and uncommon set of diseases called interstitial lung diseases. These can be deadly with a high mortality, and I’ve had the benefit of living through two approved therapies, with more coming, from an era that had none." —Imre Noth, MD, Professor of the Department of Medicine, Chief of the Division of Pulmonary and Critical Care Medicine

    Watch Video

Connect with us